Michael Roger Harrison

Associate Professor of Medicine
Member of the Duke Cancer Institute
Email address michael.harrison@duke.edu

Grants

Publications

Brousell, SC, Fantony, JJ, Van Noord, MG, Harrison, MR, and Inman, BA. "Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract: an evidence-based review of safety, efficacy, and place in therapy." Core Evidence 13 (January 24, 2018): 1-12. (Review)

PMID
29416444
Full Text

Gopalakrishna, A, Longo, TA, Fantony, JJ, Harrison, MR, and Inman, BA. "Physical activity patterns and associations with health-related quality of life in bladder cancer survivors." Urologic Oncology 35, no. 9 (September 2017): 540.e1-540.e6.

PMID
28527621
Full Text

Gopalakrishna, A, Longo, TA, Fantony, JJ, Harrison, MR, and Inman, BA. "Physical activity patterns and associations with health-related quality of life in bladder cancer survivors." UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS 35, no. 9 (September 2017).

Full Text

Ramalingam, S, Humeniuk, MS, Hu, R, Rasmussen, J, Healy, P, Wu, Y, Harrison, MR, Armstrong, AJ, George, DJ, and Zhang, T. "Prostate-specific antigen response in black and white patients treated with abiraterone acetate for metastatic castrate-resistant prostate cancer." Urol Oncol 35, no. 6 (June 2017): 418-424.

PMID
28126272
Full Text

Motzer, RJ, Jonasch, E, Agarwal, N, Bhayani, S, Bro, WP, Chang, SS, Choueiri, TK, Costello, BA, Derweesh, IH, Fishman, M, Gallagher, TH, Gore, JL, Hancock, SL, Harrison, MR, Kim, W, Kyriakopoulos, C, LaGrange, C, Lam, ET, Lau, C, Michaelson, MD, Olencki, T, Pierorazio, PM, Plimack, ER, Redman, BG, Shuch, B, Somer, B, Sonpavde, G, Sosman, J, Dwyer, M, and Kumar, R. "Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology." J Natl Compr Canc Netw 15, no. 6 (June 2017): 804-834.

PMID
28596261
Full Text

Bhavsar, NA, Harrison, MR, Hirsch, BR, Creel, P, Wolf, SP, Samsa, GP, Abernethy, AP, Simantov, R, Borham, A, and George, DJ. "Design and Rationale of the Metastatic Renal Cell Carcinoma (MaRCC) Registry: A Prospective Academic and Community-Based Study of Patients With Metastatic Renal Cell Cancer." Cancer Invest 35, no. 5 (May 28, 2017): 333-344.

PMID
28368708
Full Text

Inman, BA, Longo, TA, Ramalingam, S, and Harrison, MR. "Atezolizumab: A PD-L1-Blocking Antibody for Bladder Cancer." Clin Cancer Res 23, no. 8 (April 15, 2017): 1886-1890. (Review)

PMID
27903674
Full Text

Madden-Fuentes, RJ, Koontz, BF, Harrison, MR, George, DJ, Davidson, B, Gilmore, BF, Moul, JW, Mantyh, C, and Peterson, AC. "How Can We Effectively Address the Medical and Psychological Concerns of Survivors of Pelvic Malignancies?." Oncology (Williston Park) 31, no. 4 (April 15, 2017): 286-294. (Review)

PMID
28412780
Scholars@Duke

Gilstrap, L, Harrison, M, Kimmick, GG, and Nohria, A. "Management of chemotherapy-associated cardiomyopathy." In Cardio-Oncology: The Clinical Overlap of Cancer and Heart Disease, 81-104. April 11, 2017.

Full Text

Armstrong, AJ, Humeniuk, MS, Healy, P, Szmulewitz, R, Winters, C, Kephart, J, Harrison, MR, Martinez, E, Mundy, K, Halabi, S, and George, D. "Phase Ib Trial of Cabazitaxel and Tasquinimod in Men With Heavily Pretreated Metastatic Castration Resistant Prostate Cancer (mCRPC): The CATCH Trial." United States. March 2017.

PMID
27862097
Full Text

Pages